Assessment of an Interferon-γ release assay for the diagnosis of latent tuberculosis infection in haemodialysis patients

Swiss Medical Weekly

Volumn 140, Issue 19-20, 2010, Pages 286-292

  Hoffmann, Matthias ^a   Tsinalis, Dimitrios ^a   Vernazza, Pietro ^a   Fierz, Walter ^b   Binet, Isabelle ^a  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^b LogoLab   (Switzerland)

Author keywords

Haemodialysis; INF release assay; LTBI; Tuberculosis

Indexed keywords

GAMMA INTERFERON; MITOGENIC AGENT;

ADULT; AGED; ARTICLE; ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIALYSIS; FEMALE; HEMODIALYSIS PATIENT; HUMAN; LATENT TUBERCULOSIS INFECTION; MALE; NUTRITIONAL STATUS; RISK FACTOR; TUBERCULOSIS;

EID: 77952408394     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Laifer G, Widmer AF, Simcock M, Bassetti S, Trampuz A, Frei R, et al. TB in a low-incidence country: differences between new immigrants, foreign-born residents and native residents. Am J Med. 2007;120(4):350-356
2. Horsburgh CR Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med. 2004;350 (20):2060-2067
3. Moore DA, Lightstone L, Javid B, Friedland JS. High rates of tuberculosis in end-stage renal failure: the impact of international migration. Emerg Infect Dis. 2002;8(1):77-78
4. Chia S, Karim M, Elwood RK, FitzGerald JM. Risk of tuberculosis in dialysis patients: a population-based study. Int J Tuberc Lung Dis. 1998;2(12):989-991
5. Queipo JA, Broseta E, Santos M, Sánchez-Plumed J, Budía A, Jiménez-Cruz F. Mycobacterial infection in a series of 1261 renal transplant recipients. Clin Microbiol Infect. 2003;9(6):518-525
6. Vandermarliere A, Van Audenhove A, Peetermans WE, Vanrenterghem Y, Maes B. Mycobacterial infection after renal transplantation in a Western population. Transpl Infect Dis. 2003;5 (1):9-15.
7. Shankar MS, Aravindan AN, Sohal PM, Kohli HS, Sud K, Gupta KL, et al. The prevalence of tuberculin sensitivity and anergy in chronic renal failure in an endemic area: tuberculin test and the risk of post-transplant tuberculosis. Nephrol Dial Transplant. 2005;20(12):2720-2724
8. Poduval RD, Hammes MD. Tuberculosis screening in dialysis patients - is the tuberculin test effective? Clin Nephrol. 2003;59 (6):436-440
9. Fang HC, Chou KJ, Chen CL, Lee PT, Chiou YH, Hung SY, et al. Tuberculin skin test and anergy in dialysis patients of a tuberculosis-endemic area. Nephron. 2002;91(4):682-687
10. Smirnoff M, Patt C, Seckler B, Adler JJ. Tuberculin and anergy skin testing of patients receiving long-term hemodialysis. Chest. 1998;113(1):25-27
11. Woeltje KF, Mathew A, Rothstein M, Seiler S, Fraser VJ. Tuberculosis infection and anergy in hemodialysis patients. Am J Kidney Dis. 1998;31(5):848-852
12. Horowitz HW, Luciano BB, Kadel JR, Wormser GP. Tuberculin skin test conversion in hospital employees vaccinated with bacille Calmette-Guerin: recent Mycobacterium tuberculosis infection or booster effect? Am J Infect Control. 1995; 23(3):181-187
13. Fine PE, Sterne JA, Ponnighaus JM, Rees RJ. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet. 1994;344(8932):1245-1249
14. Lalvani A. Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest. 2007;131(6):1898-1906 (Pubitemid 46981652)
15. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007;146 (5):340-354 (Pubitemid 351650594)
16. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet. 2000;356(9235): 1099-1104
17. Pai M, Riley LW, Colford JM Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis. 2004;4(12):761-776 (Pubitemid 39574348)
18. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med. 2008;177(10):1164-1170
19. Doherty TM, Demissie A, Olobo J, Wolday D, Britton S, Eguale T, et al. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol. 2002; 40(2):704-706
20. Sester U, Sester M, Hauk M, Kaul H, Köhler H, Girndt M. T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients. Nephrol Dial Transplant. 2000;15(8):1217-1223
21. Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I. Disturbances of acquired immunity in hemodialysis patients. Semin Dial. 2007;20(5):440-451
22. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volumeKt/V: an analysis of error. J Am Soc Nephrol. 1993;4(5):1205-1213
23. European Best Practice Guidelines Expert Group on Hemodialysis, European Renal Association. Section II. Haemodialysis adequacy. Nephrol Dial Transplant. 2002;17(Suppl 7):16-31.
24. Jindal KK, Goldstein MB. Urea kinetic modeling in chronic hemodialysis: Benefits, problems, and practical solutions. Semin Dial. 1988;1:82-85
25. Anonymous. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep. 2000;49(RR-6):1-51.
26. European Best Practice Guidelines Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.7.2. Late infections. Tuberculosis. Nephrol Dial Transplant. 2002;17(Suppl 4):39-43.
27. Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of Bacille Camette Guérin vaccination on the tuberculin skin test measurements. Thorax. 2002;57:804-809
28. Hoffmann M, Reichmuth M, Fantelli K, Schoch OD, Fierz W, Furrer H, et al. Conventional tuberculin skin testing versus Tcell-based assays in the diagnosis of latent tuberculosis infection in HIV-positive patients. AIDS. 2007;21(3):390-392
29. Luetkemeyer AF, Charlebois ED, Flores LL, Bangsberg DR, Deeks SG, Martin JN, et al. Comparison of an interferon-gamma release assay with tuberculin skin testing in HIVinfected individuals. Am J Respir Crit Care Med. 2007;175(7): 737-742
30. Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen LR, Ravn P. Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test. Respir Res. 2006;7:56.
31. Matulis G, Juni P, Villiger PM, Gadola SD. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay. Ann Rheum Dis. 2008;67(1):84-90.
32. Kobashi Y, Mouri K, Obase Y, Fukuda M, Miyashita N, Oka M. Clinical evaluation of QuantiFERON TB-2G test for immuno-compromised patients. Eur Respir J. 2007;30(5):945-950
33. Piana F, Codecasa LR, Cavallerio P, Ferrarese M, Migliori GB, Barbarano L, et al. Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients. Eur Respir J. 2006;28(1):31-34 (Pubitemid 44914257)
34. Passalent L, Khan K, Richardson R, Wang J, Dedier H, Gardam M. Detecting latent tuberculosis infection in hemodialysis patients: a head-to-head comparison of the T-SPOT.TB test, tuberculin skin test, and an expert physician panel. Clin J Am Soc Nephrol. 2007;2(1):68-73.
35. Winthrop KL, Nyendak M, Calvet H, Oh P, Lo M, Swarbrick G, et al. Interferon-gamma Release Assays for Diagnosing Mycobacterium tuberculosis Infection in Renal Dialysis Patients. Clin J Am Soc Nephrol. 2008;3(5):1357-1363
36. Lee SS, Chou KJ, Su IJ, Chen YS, Fang HC, Huang TS, et al. High Prevalence of Latent Tuberculosis Infection in Patients in End-Stage Renal Disease on Hemodialysis: Comparison of QuantiFERON-TB GOLD, ELISPOT, and Tuberculin Skin Test. Infection. 2009;37(2):96-102.
37. Triverio PA, Bridevaux PO, Roux-Lombard P, Niksic L, Rochat T, Martin PY, et al. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients. Nephrol Dial Transplant. 2009;24(6):1952-1956
38. Harada N, Higuchi K, Yoshiyama T, Kawabe Y, Fujita A, Sasaki Y, et al. Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M. tuberculosis infection. J Infect. 2008;56(5):348-353
39. Girndt M, Sester U, Sester M, Kaul H, Kohler H. Impaired cellular immune function in patients with end-stage renal failure. Nephrol Dial Transplant. 1999;14(12):2807-2810
40. Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet. 2004;364(9452):2196-2203
41. Inoue T, Nakamura T, Katsuma A, Masumoto S, Minami E, Katagiri D, et al. The value of QuantiFERON TB-Gold in the diagnosis of tuberculosis among dialysis patients. Nephrol Dial Transplant. 2009;24(7):2252-2257
42. Sester M, Sester U, Clauer P, Heine G, Mack U, Moll T, et al. Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients. Kidney Int. 2004;65(5):1826-1834
43. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med. 2007;357(25):2601-2614
44. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis. 1998;27(5):1266-1277 (Pubitemid 29242482)
45. World Health Organisation. Global tuberculosis control: surveillance, planning, financing. WHO report 2007. Geneva, World Health Organization (WHO/HTM/TB/2007.376). Available from: http://www.who.int/tb/publications/ global-report/ 2007/en/index.html